Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Experimental Biology and Medicine (Maywood, N.J.)
|
March 24, 2021
Qualification of translational safety biomarkers
John-Michael Sauer, Amy C Porter
Experimental Biology and Medicine (Maywood, N.J.)
|
November 25, 2017
Preclinical biomarker qualification
John-Michael Sauer, Amy C Porter,
Journal of Neurotrauma
|
March 30, 2017
The 5th Annual One Mind Summit: Lessons Learned About "Science Informing Brain Health Policies and Practice"
Ramona Hicks, Stephen Johnson, Amy C Porter, et al.
Neurochemical Research
|
September 24, 2005
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain
Richard P Bazinet, Ho-Joo Lee, Christian C Felder, et al.
The Journal of Biological Chemistry
|
August 5, 2004
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide
Matthew J McFarland, Amy C Porter, Fariborz R Rakhshan, et al.
Life Sciences
|
January 22, 2003
Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes
Amy C Porter, Samuel P S Svensson, W Daniel Stamer, et al.
Brain Research
|
July 11, 2002
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Amy C Porter, Frank P Bymaster, Neil W DeLapp, et al.
Plos One
|
May 15, 2020
Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments
Shelli Schomaker, David Potter, Roscoe Warner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
Amy C Porter, John-Michael Sauer, Michael D Knierman, et al.
Inflammatory Bowel Diseases
|
August 26, 2020
Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions
Amy C Porter, Jiri Aubrecht, Chandler Birch, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Experimental Biology and Medicine (Maywood, N.J.)
|
March 24, 2021
Qualification of translational safety biomarkers
John-Michael Sauer, Amy C Porter
Experimental Biology and Medicine (Maywood, N.J.)
|
November 25, 2017
Preclinical biomarker qualification
John-Michael Sauer, Amy C Porter,
Journal of Neurotrauma
|
March 30, 2017
The 5th Annual One Mind Summit: Lessons Learned About "Science Informing Brain Health Policies and Practice"
Ramona Hicks, Stephen Johnson, Amy C Porter, et al.
Neurochemical Research
|
September 24, 2005
Rapid high-energy microwave fixation is required to determine the anandamide (N-arachidonoylethanolamine) concentration of rat brain
Richard P Bazinet, Ho-Joo Lee, Christian C Felder, et al.
The Journal of Biological Chemistry
|
August 5, 2004
A role for caveolae/lipid rafts in the uptake and recycling of the endogenous cannabinoid anandamide
Matthew J McFarland, Amy C Porter, Fariborz R Rakhshan, et al.
Life Sciences
|
January 22, 2003
Alpha-2 adrenergic receptors stimulate actin organization in developing fetal rat cardiac myocytes
Amy C Porter, Samuel P S Svensson, W Daniel Stamer, et al.
Brain Research
|
July 11, 2002
M1 muscarinic receptor signaling in mouse hippocampus and cortex
Amy C Porter, Frank P Bymaster, Neil W DeLapp, et al.
Plos One
|
May 15, 2020
Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments
Shelli Schomaker, David Potter, Roscoe Warner, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 23, 2002
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor
Amy C Porter, John-Michael Sauer, Michael D Knierman, et al.
Inflammatory Bowel Diseases
|
August 26, 2020
Biomarkers of Crohn's Disease to Support the Development of New Therapeutic Interventions
Amy C Porter, Jiri Aubrecht, Chandler Birch, et al.
Page
of 2